Brought to you by

Lilly gets commercialization rights to Zosano's osteoporosis patch; deal ends
22 Sep 2017
Executive Summary
Zosano Pharma Corp. granted Eli Lilly & Co. exclusive global commercialization rights to ZPPTH, its microneedle patch system that has completed Phase II for severe osteoporosis.
Deal Industry
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Macromolecule
- Transdermal
-
Drug Delivery
-
Biotechnology
- Large Molecule
Deal Status
- Terminated
Deal Type
-
Alliance
- Includes Equity
- Includes Royalty or Profit Split Information
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com